Skip to Content
  • Previous Rank979
  • Revenues ($M)$2,075.40
  • Revenue Percent Change12.3%
  • Profits ($M)$109.8
  • Profits Percent Change-1.5%
  • Assets ($M)$3,454.30
  • Employees10,800
  • Market Value — as of March 29, 2018 ($M)$5,474.10
Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
John R. Chiminski
CEO Title
Chairman, President & Chief Executive Officer
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
Somerset, N.J.
Websitehttp://www.catalent.com
Years on Fortune 500 List-
Employees10,800
Figures are for fiscal year ended June 30, 2017.

Catalent Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$2,075.4012.3%
Profits ($M)$109.8-1.5%
Assets ($M)$3,454.30-
Total Stockholder Equity ($M)$723.5-
Market Value — as of March 29, 2018 ($M)$5,474.10-

Profit Ratios

Profit as % of Revenues5.3%
Profits as % of Assets3.2%
Profits as % of Stockholder Equity15.2%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)0.87
EPS % Change (from 2016)-2.2%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2017)52.4%
Total Return to Investors (5 year, annualized)-
Total Return to Investors (10 year, annualized)-